Vector Group Releases Record Tobacco Revenue in 2022

Feb.17.2023
Vector Group Releases Record Tobacco Revenue in 2022
Vector Group reports record tobacco revenue driven by strong sales, achieving historic highs in 2022.

Vector Group has released its annual report for 2022, which highlights a record high in tobacco business revenue bolstered by persistent strong sales.


Vector Group reported a consolidated revenue of $363.8 million in the fourth quarter, marking a 16% increase from the same period last year, or an additional $50.1 million. Revenue from their tobacco business also rose by 18.6%, or $57.2 million, to reach $363.8 million. The wholesale and retail market share for the tobacco sector increased from 4.4% to 5.5% and 4.4% to 5.8%, respectively. Operating revenue stood at $89.3 million, representing an increase of $20.7 million year-over-year. The tobacco sector's operating revenue amounted to $93 million, an 11% increase, or $9.2 million, attributed mainly to the Montego brand's switch to a revenue-based strategy instead of sales volume-based.


Throughout the year, Vector Group's total revenue amounted to $1.44 billion, marking an 18% increase from the previous year, or a $220.3 million increase. Within the company, the tobacco division brought in $1.43 billion in revenue, showing an 18.5% growth from the same period the year before, or a $222.6 million increase. The division's market shares in both wholesale and retail increased from 4.1% and 4.2%, respectively, to 5.4% and 5.5%. As for the reported operating revenue, it totaled $339 million and increased by $18.6 million from the previous year. The tobacco division's operating revenue was $347 million, a 3.7% decrease from the same period the year before, or a $13.3 million decrease, which was mainly due to the investment in the Montego brand that significantly increased its sales and market share.


Howard M. Lorber, President and CEO of Vector Group, stated that by seizing opportunities and significantly increasing market share, the company has created value for shareholders and achieved a historic high in revenue for 2022. The tobacco business saw an 11% increase in revenue in the fourth quarter, reflecting a shift in strategy for the Montego brand from volume-based to profit-based. In 2023, Vector Group will continue to focus on optimizing long-term profits through effective management of sales volume, pricing, and market share.


Vector Group Ltd. is a diversified holding company headquartered in Miami, Florida, with administrative offices in Manhattan and tobacco operations in North Carolina. Through its subsidiaries - Liggett Group LLC and Vector Tobacco Inc. - the company produces and sells high-quality tobacco-related products for adult smokers in the United States.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Special Report | 71 U.S. Lawmakers Seek to Elevate Illicit Vape Crackdown to U.S.–China Trade Negotiations
Special Report | 71 U.S. Lawmakers Seek to Elevate Illicit Vape Crackdown to U.S.–China Trade Negotiations
U.S. Rep.Mike Carey and 70 other Republican lawmakers have urged federal officials to elevate the crackdown on illicit vapes to the U.S.–China trade agenda. In a March 4 letter to the Treasury Secretary and the U.S. Trade Representative, they warned that unauthorized vape products pose risks related to national security, youth protection and organized crime. The signatories represent about one-third of House Republicans, highlighting growing congressional attention to illicit vape trade.
Mar.10
Tennessee’s “Tobacco Product Retail Licensing Act” Would Require New Licenses for Tobacco and Vapes
Tennessee’s “Tobacco Product Retail Licensing Act” Would Require New Licenses for Tobacco and Vapes
A newly introduced Tennessee bill, S.B. 2086, would create a statewide tobacco product retail licensing system, move oversight to the Tennessee Alcohol Commission, and impose fees and escalating penalties. The proposal also requires all tobacco product sales to occur as in-person, over-the-counter transactions at licensed locations—effectively banning direct-to-consumer shipping of cigars and potentially restricting curbside or phone-order pickup models.
Jan.28 by 2FIRSTS.ai
Michigan Senate Bill 786 Seeks to Ban Sale of Vapes With Metal Heating Elements
Michigan Senate Bill 786 Seeks to Ban Sale of Vapes With Metal Heating Elements
Michigan lawmakers introduced Senate Bill 786 on February 18, 2026, proposing to prohibit the sale or transfer of vapor products that contain heating elements unless those elements are made of or encased in glass or ceramic materials
Regulations
Feb.21
Costa Rica’s Constitutional Court Rejects Challenge, New Vape Rules to Take Effect on August 6
Costa Rica’s Constitutional Court Rejects Challenge, New Vape Rules to Take Effect on August 6
Costa Rica’s Constitutional Court has rejected an injunction seeking to stop a new vape regulation from taking effect, ruling that there was no specific harm to constitutional rights. As a result, Technical Regulation RTCR 519-2025, promoted by the Health Ministry, will enter into force on August 6 as originally planned.
Mar.20 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Imperial Brands Forms Global AI Partnership with Capgemini, Reinforcing Artificial Intelligence as Core Infrastructure in the Nicotine Industry
Imperial Brands Forms Global AI Partnership with Capgemini, Reinforcing Artificial Intelligence as Core Infrastructure in the Nicotine Industry
Industry Insight
Feb.19